Epidemiology and Clinical Outcomes of HTLV-1: A Comprehensive Narrative Review of Endemic and Nonendemic Regions. [PDF]
Noori B +5 more
europepmc +1 more source
Identification of Non-basic Matrix Domain Residues That Impact HTLV-1 Gag Membrane Targeting and Particle Release. [PDF]
Meng S +8 more
europepmc +1 more source
Seroprevalence Assessment of HTLV-1 and Its Related Risk Factors in Patients With Rheumatoid Arthritis in Gonabad in 2023. [PDF]
Tehranian F +3 more
europepmc +1 more source
Transcriptomic and Epitranscriptomic Landscape of Integrated HTLV-1 in MT2 Cells. [PDF]
Wei S +8 more
europepmc +1 more source
Heterogeneity of HTLV-1 proviral integration sites and internal structures in the ATL cell line MT-1. [PDF]
Izaki M +4 more
europepmc +1 more source
Le rôle ambivalent de l'interféron alpha au cours des infections par HTLV-1 et HTLV-2
HTLV-1 and HTLV-2 viruses are responsible for life-long infections. After a long latency period, 2 to 5 % of HTLV-1 infected people develop diseases such as Adult T cell leukemia (ATL) or Tropical Spastic Paraparesis/HTLV-1 associated Myelopathy (TSP/HAM)
Cachat, Anne
core
Whole Blood Volume-Based Absolute Quantification of HTLV-1 Proviral Load: A Comparative Method Evaluation Study. [PDF]
Franco GO +4 more
europepmc +1 more source
Design and evaluation patient portal for patients with HTLV-1. [PDF]
Norouzi Aval R +4 more
europepmc +1 more source
FC-duplex IgG1 (HTLV-1/2): Qualifying the flow cytometry IgG1 duplex assay for differential diagnosis of HTLV-1 and HTLV-2 infections. [PDF]
Martins JP +14 more
europepmc +1 more source
HIV/HTLV-1/2 Co-Infection in the Peruvian Amazon: Prevalence and Associated Factors. [PDF]
Alava-Flores WG +4 more
europepmc +1 more source

